About My Health Careers Internship MedBlogs Contact us
Medindia LOGIN REGISTER
Advertisement

New Target for Immunotherapy for Solid Tumors Identified

by Hannah Joy on April 25, 2018 at 4:12 PM
Font : A-A+

New Target for Immunotherapy for Solid Tumors Identified

A new target that has the potential to help T cells or white blood cells infiltrate certain solid tumors has been identified, reveals a new study by the University of Cincinnati (UC).

This study, being published in the online edition of the journal Science Signaling, showed that by targeting a certain potassium channel--KCa3.1--the CD8+ T cell migration in patient samples was restored, meaning that they could potentially be more effective in moving in on the tumor and attacking it. CD8+ cells are a type of T cell capable of killing cancer cells.

Advertisement


"Reduced potassium channel activity curbs T cell movement within the tumor," says Laura Conforti, PhD, professor in the Department of Internal Medicine at the UC College of Medicine, a researcher within the Cincinnati Cancer Center and UC Cancer Institute and corresponding author on the study.

"T cell infiltration in solid tumors is limited by multiple factors found within the tumor's microenvironment, including adenosine, an immunosuppressive substance accumulating in high amounts in solid tumors."
Advertisement

Conforti and her team, led by Ameet Chimote, PhD, a research associate in the Department of Internal Medicine, analyzed the migration of CD8+ T cells in a 3-D experimental model system that allows the reproduction of some features of the tumor microenvironment and found that when adenosine was present, it inhibited the movement of T cells from cancer patients more than T cells from healthy donors.

"The increased sensitivity of patient CD8+ T cells to adenosine correlated with reduced KCa3.1 channel activity, but not with adenosine receptor expression or signaling," she says.

"Treatment with a substance that restores the KCa3.1 channel activity corrects patient CD8+ T cell migration in the presence of adenosine, suggesting that potassium channel activators may help enhance T cell infiltration of adenosine-rich solid tumors, providing another therapy option.

"This finding could lead to the development of new therapeutic agents to use in combination with approved immunomodulators for the treatment of solid tumors, as they may improve their efficacy."



Source: Eurekalert
Advertisement

Advertisement
News A-Z
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
Advertisement
News Category
What's New on Medindia
International Day of Persons with Disabilities 2021 - Fighting for Rights in the Post-COVID Era
Effect of Blood Group Type on COVID-19 Risk and Severity
Woman with Rare Spinal Cord Defect from Birth Sues Doctor
View all

Medindia Newsletters Subscribe to our Free Newsletters!
Terms & Conditions and Privacy Policy.

More News on:
Immunisation Dealing with Pollen Allergy Immune Checkpoint Inhibitors for Cancer Treatment 

Recommended Reading
FDA Approves Immunotherapy Drug Combination of Ipilimumab, Nivolumab to Treat Kidney Cancer
A combination of two immunotherapy drugs, ipilimumab and nivolumab has been approved by FDA to ......
Nanodisc Based Delivery of Cancer Immunotherapy Drugs
Novel platform for chemo-immunotherapy eliminated colon cancer in 85 percent of treated mice...
Immunotherapy More Effective and Long Lasting If T Cell ‘memory’ is Boosted
New study provides insight into memory T cell formation and disease relapse in cancer ......
Positive Results Shown by Phase III Immunotherapy Trial for Migraine
An antibody therapy against a key inflammatory molecule involved in migraines reduces the number of ...
Dealing with Pollen Allergy
The plants around you that give you sniffles in your nose at specific time of the year are the sourc...
Immune Checkpoint Inhibitors for Cancer Treatment
Immune checkpoint inhibitors are promising drugs to treat a variety of cancers and the FDA has appro...

Disclaimer - All information and content on this site are for information and educational purposes only. The information should not be used for either diagnosis or treatment or both for any health related problem or disease. Always seek the advice of a qualified physician for medical diagnosis and treatment. Full Disclaimer

© All Rights Reserved 1997 - 2021

This site uses cookies to deliver our services. By using our site, you acknowledge that you have read and understand our Cookie Policy, Privacy Policy, and our Terms of Use